Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076336
Company: ACTAVIS LABS FL INC

• Other Important Information from FDA

Products on ANDA 076336

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MIRTAZAPINE	MIRTAZAPINE	15MG	TABLET;ORAL	Discontinued	None	No	No
MIRTAZAPINE	MIRTAZAPINE	30MG	TABLET;ORAL	Discontinued	None	No	No
MIRTAZAPINE	MIRTAZAPINE	45MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 076336

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/20/2003	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/05/2007	SUPPL-7	Labeling		Label is not available on this site.
11/06/2006	SUPPL-6	Labeling		Label is not available on this site.
04/28/2005	SUPPL-5	Labeling		Label is not available on this site.
04/28/2005	SUPPL-3	Labeling		Label is not available on this site.